<DOC>
	<DOCNO>NCT01966627</DOCNO>
	<brief_summary>This study investigate genetic predisposition hepatic steatosis expression gluconeogenic lipogenic gene liver obese child adolescent . Hypothesis 1 : Common variant recently associate variation plasma TG level identify Genome Wide Association Studies ( GWAS ) ( GCKR , PNPLA3 ) affect accumulation fat subsequent development Non Alcoholic Fatty Liver Disease ( NAFLD ) . Gene variant act additive synergistic manner progressive liver fat accumulation per additional risk allele . Hypothesis 2 : With increase hepatic fat content NASH fibrosis increase . Furthermore , expression lipogenic marker ( SREBP1c ) increase .</brief_summary>
	<brief_title>Genetics Fatty Liver Disease Children</brief_title>
	<detailed_description>To establish cohort obese youth prospectively analyze potential factor ( genetic nutritional factor ) might affect expression progression NAFLD . This study determine genetic marker ability convey susceptibility NAFLD obese child adolescent . Furthermore , potential mechanism might contribute accumulation hepatic Triglyceride ( TG ) accumulation , first time , assess genotyping . Additionally , examine presence intestinal microbiome development fatty liver stool collection .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>7 18 year age , overweight obese BMI great 85th percentile age gender , otherwise healthy . use medication alters liver function , blood pressure , glucose lipid metabolism use antipsychotic medication Youth chronic antiinflammatory medication consume alcohol also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>non alcoholic fatty liver</keyword>
	<keyword>childhood obesity</keyword>
	<keyword>genetic variant</keyword>
</DOC>